Literature DB >> 23423537

Agrypnia excitata.

Federica Provini1.   

Abstract

Agrypnia (from the Greek: to chase sleep) excitata (AE) is a syndrome characterized by loss of sleep and permanent motor and autonomic hyperactivation (excitata). Disruption of the sleep-wake rhythm consists in the disappearance of spindle-delta activities, and the persistence of stage 1 non-rapid eye movement (NREM) sleep. Rapid eye movement (REM) sleep persists but fails to stabilize, appearing in short recurrent episodes, isolated, or mixed with stage 1 NREM sleep. Diurnal and nocturnal motor, autonomic and hormonal overactivity is the second hallmark of AE. Of particular interest is the finding that norepinephrine secretion is extremely elevated at all hours of the day and night whereas the nocturnal melatonin peak is lacking. Oneiric stupor is probably an exclusive sign of AE and consists in the recurrence of stereotyped gestures mimicking simple daily life activities. Agrypnia excitata aptly defines 3 different clinical conditions, fatal familial insomnia (FFI), an autosomal dominant prion disease, Morvan syndrome (MS), an autoimmune encephalitis, and delirium tremens (DT), the alcohol withdrawal syndrome. Agrypnia excitata is due to an intralimbic disconnection releasing the hypothalamus and brainstem reticular formation from cortico-limbic inhibitory control. This pathogenetic mechanism is visceral thalamus degeneration in FI, whereas it may depend on autoantibodies blocking voltage-gated potassium (VGK) channels within the limbic system in MS, and in the sudden changes in gabaergic synapses down-regulated by chronic alcohol abuse within the limbic system in DT.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23423537     DOI: 10.1007/s11910-013-0341-8

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  43 in total

Review 1.  Agrypnia excitata.

Authors:  Elio Lugaresi; Federica Provini; Pietro Cortelli
Journal:  Sleep Med       Date:  2011-12       Impact factor: 3.492

2.  Oneiric stupor: the peculiar behaviour of agrypnia excitata.

Authors:  Pietro Guaraldi; Giovanna Calandra-Buonaura; Rossana Terlizzi; Pasquale Montagna; Elio Lugaresi; Paolo Tinuper; Pietro Cortelli; Federica Provini
Journal:  Sleep Med       Date:  2011-12       Impact factor: 3.492

3.  Sleep manifestations of voltage-gated potassium channel complex autoimmunity.

Authors:  Jason R Cornelius; Sean J Pittock; Andrew McKeon; Vanda A Lennon; Paula A Aston; Keith A Josephs; Maja Tippmann-Peikert; Michael H Silber
Journal:  Arch Neurol       Date:  2011-06

4.  Korsakoff's syndrome: radiological (CT) findings and neuropsychological correlates.

Authors:  A P Shimamura; T L Jernigan; L R Squire
Journal:  J Neurosci       Date:  1988-11       Impact factor: 6.167

5.  Reduced sleep in Drosophila Shaker mutants.

Authors:  Chiara Cirelli; Daniel Bushey; Sean Hill; Reto Huber; Robert Kreber; Barry Ganetzky; Giulio Tononi
Journal:  Nature       Date:  2005-04-28       Impact factor: 49.962

6.  Agrypnia excitata: clinical features and pathophysiological implications.

Authors:  Elio Lugaresi; Federica Provini
Journal:  Sleep Med Rev       Date:  2001-08       Impact factor: 11.609

Review 7.  Familial and sporadic fatal insomnia.

Authors:  Pasquale Montagna; Pierluigi Gambetti; Pietro Cortelli; Elio Lugaresi
Journal:  Lancet Neurol       Date:  2003-03       Impact factor: 44.182

8.  Fatal familial insomnia, a prion disease with a mutation at codon 178 of the prion protein gene.

Authors:  R Medori; H J Tritschler; A LeBlanc; F Villare; V Manetto; H Y Chen; R Xue; S Leal; P Montagna; P Cortelli
Journal:  N Engl J Med       Date:  1992-02-13       Impact factor: 91.245

Review 9.  Fatal familial insomnia and agrypnia excitata.

Authors:  Elio Lugaresi; Federica Provini
Journal:  Rev Neurol Dis       Date:  2007

Review 10.  Molecular pathology of fatal familial insomnia.

Authors:  P Parchi; R B Petersen; S G Chen; L Autilio-Gambetti; S Capellari; L Monari; P Cortelli; P Montagna; E Lugaresi; P Gambetti
Journal:  Brain Pathol       Date:  1998-07       Impact factor: 6.508

View more
  9 in total

1.  Fulminant corticobasal degeneration: Agrypnia excitata in corticobasal syndrome.

Authors:  Federico Rodriguez-Porcel; Lindsey Lowder; Rosa Rademakers; Thomas Ravenscroft; Bernardino Ghetti; Mathew C Hagen; Alberto J Espay
Journal:  Neurology       Date:  2016-02-12       Impact factor: 9.910

2.  A Case of Recurrent Insomnia: Extending the Spectrum of Autoimmune Encephalitis.

Authors:  Priyanka Sabharwal; Mandana Mahmoudi; Nisida Berberi; Blanca A Vasquez; Daniel Friedman; Sanjeev V Kothare
Journal:  J Clin Sleep Med       Date:  2016-05-15       Impact factor: 4.062

3.  Electrophysiological Evaluation in Identifying Unique Sleep Features Among Anti-LGI1 Encephalitis Patients During Active and Recovery Phase.

Authors:  Xiaoyun Liu; Liling Yang; Yabo Feng; Youting Lin; Yuxiang Han; Jingjing Xu; Zaiying Pang; Yifeng Du
Journal:  Nat Sci Sleep       Date:  2021-05-03

4.  Strategies of Functional Foods Promote Sleep in Human Being.

Authors:  Yawen Zeng; Jiazhen Yang; Juan Du; Xiaoying Pu; Xiaomen Yang; Shuming Yang; Tao Yang
Journal:  Curr Signal Transduct Ther       Date:  2014-12

Review 5.  Differentiating Oneiric Stupor in Agrypnia Excitata From Dreaming Disorders.

Authors:  Luca Baldelli; Federica Provini
Journal:  Front Neurol       Date:  2020-11-12       Impact factor: 4.003

6.  Anti-NMDA-receptor encephalitis: an unusual treatable cause of chronic insomnia?

Authors:  Wietse A Wiels; Yacine Boudiba; Laura Seynaeve; Sylvie De Raedt
Journal:  Sleep Sci       Date:  2021 Jul-Sep

7.  Specific structuro-metabolic pattern of thalamic subnuclei in fatal familial insomnia: A PET/MRI imaging study.

Authors:  Kexin Xie; Yaojing Chen; Min Chu; Yue Cui; Zhongyun Chen; Jing Zhang; Li Liu; Donglai Jing; Chunlei Cui; Zhigang Liang; Liankun Ren; Pedro Rosa-Neto; Imad Ghorayeb; Zhanjun Zhang; Liyong Wu
Journal:  Neuroimage Clin       Date:  2022-04-26       Impact factor: 4.891

8.  Sleep disturbances in craniopharyngioma: a challenging diagnosis.

Authors:  Ramona Cordani; Marco Veneruso; Flavia Napoli; Claudia Milanaccio; Antonio Verrico; Alessandro Consales; Matteo Cataldi; Daniela Fava; Natascia Di Iorgi; Mohamad Maghnie; Maria Margherita Mancardi; Lino Nobili
Journal:  J Neurol       Date:  2021-09-14       Impact factor: 4.849

9.  Agrypnia excitata and obstructive apnea in a patient with fatal familial insomnia from China: A case report.

Authors:  Congcong Sun; Wen Xia; Ying Liu; Guoyong Jia; Cuilan Wang; Chuanzhu Yan; Yi Li
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.